OG-Cx-833

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameOG-Cx-833

Drug Alias NameLSD-1/MAO-B inhibitor (Oryzon Genomics)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMonoamine oxidase B inhibitorsLysine-specific histone demethylase 1 inhibitors

TargetsMonoamine oxidase BLysine-specific histone demethylase 1

Therapy Area/IndicationsHuntington Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryEurope

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesOryzon Genomics Sa

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsHuntington Disease

ATC CodeN/A